Snuff - How dangerous is it? The controversy continues

Journal of Internal Medicine

Volumn 250, Issue 6, 2001, Pages 457-461

  Asplund, K ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE GUM; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON;

ADDICTION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; EDITORIAL; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL CARCINOMA; HEALTH HAZARD; HEART INFARCTION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKELESS TOBACCO; SWEDEN; TOBACCO INDUSTRY; UNITED STATES; UROGENITAL TRACT CANCER;

CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; PLANTS, TOXIC; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TOBACCO, SMOKELESS;

EID: 0035655559     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00918.x     Document Type: Editorial

References (54)

1. Differences of tobacco use in Vietnamese, African-American, Hispanic, and Caucasian adolescents in Worcester, Massachusetts
2. Moist snuff in Sweden - Tradition and evolution
3. Tobacco use by early adolescents in Norway
4. The prevalence of betel-quid and tobacco chewing among the Bangladesh community residents in a United Kingdom area of multiple deprivation
5. Epidemiology of cancer by tobacco products and the significance of TSNA
6. Toombak use and cigarette smoking in the Sudan: Estimates of prevalence in the Nile state
7. Smokeless tobacco use among urban white and black South Africans
8. Use of smokeless tobacco by Mexican-American high school students
9. Surveillance for selected tobacco-use behaviors
10. Epidemiology of tobacco use among US adolescents
11. Smokeless Tobacco, Cardiovascular Risk Factors, and Nicotine and Cotinine Levels in Professional Baseball Players
12. Prevalence, patterns, and correlates of spit tobacco use in a college athlete population
13. US college students' use of tobacco products: Results of a national survey
14. Smokeless tobacco use and atherosclerosis: An ultrasonographic investigation of carotid intima thickness in healthy middle-aged men
15. Smokeless tobacco use and increased cardiovascular mortality
16. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year old men
17. Use of smokeless tobacco and cigarettes - Effects on plasma levels of antioxidant vitamins
18. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Swe-den MONICA Study
19. Tobacco and myocardial infarction: Is snuff less dangerous than cigarettes?
20. Smokeless tobacco as a possible risk factor for myocardial infarction. A population-based study in middle-aged men
21. Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum
22. Cardiovascular risk factors in young snuff-users and cigarette smokers
23. Uptake and metabolism of carcinogenic levels of tobacco-specific nitros-amines by Sudanese snuff dippers
24. Tobacco-specific nitrosamine adducts: Studies in laboratory animals and humans
25. Prädisponierende Faktoren für Plat-tenepithelkarzinom in Mund, Hals and Speiseröhre. Eine Stastische Undersuchung am Material des Radiumhemmets, Stockholm
26. National Institutes of Health consensus statement. Health implications of smokeless tobacco use
27. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study
28. Oral cancer in a tobacco-chewing US population - No apparent increased incidence or mortality
29. A qualitative and quantitative risk assessment of snuff dipping
30. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia
31. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance
32. Cigarette smoking, oral moist snuff use and glucose intolerance
33. Nicotine intake and dependence in Swedish snuff takers
34. Who is a successful quitter? One-year follow-up of a National Quit and Win Contest in Sweden
35. Smokeless tobacco cessation intervention for college athletes: Results after 1 year
36. Smokeless tobacco cessation
37. A self-help cessation program for smokeless tobacco users. Comparison of two interventions
38. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy
39. Tobacco habits other than smoking; betel quid and avoca nut chewing; and some related nitrosamines
40. 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development
41. The need for regulation of carcinogenic N-nitrosamines in oral snuff
42. Five leading US commercial brands of moist snuff in 1994: Assessment of carcinogenic N-nitrosamines
43. Evidence that smokeless tobacco is a gateway for smoking initiation in young adult males
44. Age of initiation and switching patterns between smokeless tobacco and cigarettes among college students in the United States
45. Snuff use and smoking among senior high school students: Effects of a snuff sales ban
46. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
47. Tobacco-related mortality
48. A pilot study of smokeless tobacco in smoking cessation
49. Treating cigarette smoking with smokeless tobacco: A flawed recommendation
50. Comments on West and Krafona's 'Oral tobacco: Prevalence, health risks, dependence potential and public policy'
51. State tobacco lobbyists and organizations in the United States: Crossed lines
52. Back to the future with oral snuff